Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Extension Phase of the Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study of E2007 (Perampanel) as an Adjunctive Therapy in Patients With Refractory Partial Seizures

NCT00368472 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00368472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00368472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Extension Phase of the Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study of E2007 (Perampanel) as an Adjunctive Therapy in Patients With Refractory Partial Seizures
Lead sponsor
Eisai Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2006
Completion date
July 31, 2014
Enrollment
138 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy